Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

[Expression of RUNX3 protein in hepatic cell carcinoma and its clinicopathological implications].

Lu YH, Zheng RD, Chen J, Chen BF, Li JG, Lin ZC.

Nan Fang Yi Ke Da Xue Xue Bao. 2011 Feb;31(2):329-32. Chinese.

2.

[The associated research on the expression of RUNX3 mRNA and protein in hepatic cell carcinoma as well as the relationship with clinical pathological parameters].

Lu YH, Zheng RD, Xu CR, Chen J, Wu WP, Chen BF, Li JG, Lin ZC.

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2011 Dec;25(6):441-4. Chinese.

PMID:
22734230
3.

Decreased expression and frequent allelic inactivation of the RUNX3 gene at 1p36 in human hepatocellular carcinoma.

Mori T, Nomoto S, Koshikawa K, Fujii T, Sakai M, Nishikawa Y, Inoue S, Takeda S, Kaneko T, Nakao A.

Liver Int. 2005 Apr;25(2):380-8.

PMID:
15780064
4.

Loss of runt-related transcription factor 3 causes development and progression of hepatocellular carcinoma.

Shiraha H, Nishina S, Yamamoto K.

J Cell Biochem. 2011 Mar;112(3):745-9. doi: 10.1002/jcb.22973. Review.

PMID:
21328447
5.

RUNX3 inhibits growth of HCC cells and HCC xenografts in mice in combination with adriamycin.

Li X, Zhang Y, Zhang Y, Qiao T, Wu K, Ding J, Liu J, Fan D.

Cancer Biol Ther. 2008 May;7(5):669-76. Epub 2008 May 1.

PMID:
18259121
6.

Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines.

Jiang Y, Tong D, Lou G, Zhang Y, Geng J.

Pathobiology. 2008;75(4):244-51. doi: 10.1159/000132385. Epub 2008 Jun 26.

7.

Loss of runt-related transcription factor 3 expression leads hepatocellular carcinoma cells to escape apoptosis.

Nakanishi Y, Shiraha H, Nishina S, Tanaka S, Matsubara M, Horiguchi S, Iwamuro M, Takaoka N, Uemura M, Kuwaki K, Hagihara H, Toshimori J, Ohnishi H, Takaki A, Nakamura S, Kobayashi Y, Nouso K, Yagi T, Yamamoto K.

BMC Cancer. 2011 Jan 4;11:3. doi: 10.1186/1471-2407-11-3.

8.

Down-regulation of CYLD as a trigger for NF-κB activation and a mechanism of apoptotic resistance in hepatocellular carcinoma cells.

Urbanik T, Köhler BC, Boger RJ, Wörns MA, Heeger S, Otto G, Hövelmeyer N, Galle PR, Schuchmann M, Waisman A, Schulze-Bergkamen H.

Int J Oncol. 2011 Jan;38(1):121-31.

PMID:
21109933
9.

[The expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma].

Liu Y, Chen X, Peng S, Fang H, Wu Y, Peng C, Shi L, Bai M, Xu B, Wang J, Deng G.

Zhonghua Yi Xue Za Zhi. 2002 Nov 25;82(22):1553-6. Chinese.

PMID:
12609066
10.

Runt-related transcription factor 3 reverses epithelial-mesenchymal transition in hepatocellular carcinoma.

Tanaka S, Shiraha H, Nakanishi Y, Nishina S, Matsubara M, Horiguchi S, Takaoka N, Iwamuro M, Kataoka J, Kuwaki K, Hagihara H, Toshimori J, Ohnishi H, Takaki A, Nakamura S, Nouso K, Yagi T, Yamamoto K.

Int J Cancer. 2012 Dec 1;131(11):2537-46. doi: 10.1002/ijc.27575. Epub 2012 Apr 24.

11.

Restored expression of the tumor suppressor gene RUNX3 reduces cancer stem cells in hepatocellular carcinoma by suppressing Jagged1-Notch signaling.

Nishina S, Shiraha H, Nakanishi Y, Tanaka S, Matsubara M, Takaoka N, Uemura M, Horiguchi S, Kataoka J, Iwamuro M, Yagi T, Yamamoto K.

Oncol Rep. 2011 Sep;26(3):523-31. doi: 10.3892/or.2011.1336. Epub 2011 May 31.

PMID:
21637926
12.

[The RUNX3 mRNA expression in hepatic cell carcinoma(HCC)].

Lu YH, Xu CR, Chen J, Zheng RD, Li JG, Lin ZC.

Zhonghua Gan Zang Bing Za Zhi. 2011 Dec;19(12):940-1. Chinese. No abstract available.

PMID:
22553801
13.

[Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma].

Lou C, Yang B, Gao YT, Wang YJ, Nie FH, Yuan Q, Zhang CL, Du Z.

Zhonghua Zhong Liu Za Zhi. 2008 Nov;30(11):831-6. Chinese.

PMID:
19173828
14.

[Determination of expression of eight p53-related genes in hepatocellular carcinoma with tissue microarrays].

Zhu MH, Ni CR, Zhu Z, Li FM, Zhang SM.

Ai Zheng. 2003 Jul;22(7):680-5. Chinese.

PMID:
12866955
15.

[Analysis of methylation and loss of heterozygosity of RUNX3 gene in hepatocellular carcinoma and its clinical significance].

Xiao WH, Liu WW.

Zhonghua Gan Zang Bing Za Zhi. 2004 Apr;12(4):227-30. Chinese.

PMID:
15099475
16.

[Expression of signal-regulatory protein alpha (SIRP alpha) in hepatocellular carcinoma].

Li B, Wang H, Chen Z.

Zhonghua Zhong Liu Za Zhi. 1998 Sep;20(5):345-7. Chinese.

PMID:
10921027
17.

Relationship between RUNX3 methylation and hepatocellular carcinoma in Asian populations: a systematic review.

Lu XX, Zhu LQ, Pang F, Sun W, Ou C, Li Y, Cao J, Hu YL.

Genet Mol Res. 2014 Jul 7;13(3):5182-9. doi: 10.4238/2014.July.7.11.

19.

Deleted in liver cancer 1 isoforms are distinctly expressed in human tissues, functionally different and under differential transcriptional regulation in hepatocellular carcinoma.

Ko FC, Yeung YS, Wong CM, Chan LK, Poon RT, Ng IO, Yam JW.

Liver Int. 2010 Jan;30(1):139-48. doi: 10.1111/j.1478-3231.2009.02133.x. Epub 2009 Oct 27.

PMID:
19874489
20.

Loss of expression of Kruppel-like factor 6 in primary hepatocellular carcinoma and hepatoma cell lines.

Wang SP, Zhou HJ, Chen XP, Ren GY, Ruan XX, Zhang Y, Zhang RL, Chen J.

J Exp Clin Cancer Res. 2007 Mar;26(1):117-24.

PMID:
17550140

Supplemental Content

Support Center